<?xml version="1.0" encoding="UTF-8"?>
<document id="DDI-DrugBank.d358">
    <sentence id="DDI-DrugBank.d358.s0" text="Since PLETAL is extensively metabolized by cytochrome P-450 isoenzymes, caution should be exercised when PLETAL is coadministered with inhibitors of C.P.A. such as ketoconazole and erythromycin or inhibitors of CYP2C19 such as omeprazole.">
        <entity id="DDI-DrugBank.d358.s0.e0" charOffset="6-11"
            type="brand" text="PLETAL"/>
        <entity id="DDI-DrugBank.d358.s0.e1" charOffset="105-110"
            type="brand" text="PLETAL"/>
        <entity id="DDI-DrugBank.d358.s0.e2" charOffset="164-175"
            type="drug" text="ketoconazole"/>
        <entity id="DDI-DrugBank.d358.s0.e3" charOffset="181-192"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d358.s0.e4" charOffset="227-236"
            type="drug" text="omeprazole"/>
        <ddi id="DDI-DrugBank.d358.s0.d0" e1="DDI-DrugBank.d358.s0.e1"
            e2="DDI-DrugBank.d358.s0.e2" type="advise"/>
        <ddi id="DDI-DrugBank.d358.s0.d1" e1="DDI-DrugBank.d358.s0.e1"
            e2="DDI-DrugBank.d358.s0.e3" type="advise"/>
        <ddi id="DDI-DrugBank.d358.s0.d2" e1="DDI-DrugBank.d358.s0.e1"
            e2="DDI-DrugBank.d358.s0.e4" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d358.s1" text="Pharmacokinetic studies have demonstrated that omeprazole and erythromycin significantly increased the systemic exposure of cilostazol and/or its major metabolites.">
        <entity id="DDI-DrugBank.d358.s1.e0" charOffset="47-56"
            type="drug" text="omeprazole"/>
        <entity id="DDI-DrugBank.d358.s1.e1" charOffset="62-73"
            type="drug" text="erythromycin"/>
        <entity id="DDI-DrugBank.d358.s1.e2" charOffset="124-133"
            type="drug" text="cilostazol"/>
        <ddi id="DDI-DrugBank.d358.s1.d0" e1="DDI-DrugBank.d358.s1.e0"
            e2="DDI-DrugBank.d358.s1.e2" type="mechanism"/>
        <ddi id="DDI-DrugBank.d358.s1.d1" e1="DDI-DrugBank.d358.s1.e1"
            e2="DDI-DrugBank.d358.s1.e2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d358.s2" text="Population pharmacokinetic studies showed higher concentrations of cilostazol among patients concurrently treated with diltiazem, an inhibitor of C.P.A..">
        <entity id="DDI-DrugBank.d358.s2.e0" charOffset="67-76"
            type="drug" text="cilostazol"/>
        <entity id="DDI-DrugBank.d358.s2.e1" charOffset="119-127"
            type="drug" text="diltiazem"/>
        <ddi id="DDI-DrugBank.d358.s2.d0" e1="DDI-DrugBank.d358.s2.e0"
            e2="DDI-DrugBank.d358.s2.e1" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d358.s3" text="Pletal does not, however, appear to cause increased blood levels of drugs metabolized by CYP3A4, as it had no effect on lovastatin, a drug with metabolism very sensitive to C.P.A. inhibition.">
        <entity id="DDI-DrugBank.d358.s3.e0" charOffset="0-5"
            type="brand" text="Pletal"/>
        <entity id="DDI-DrugBank.d358.s3.e1" charOffset="120-129"
            type="drug" text="lovastatin"/>
    </sentence>
</document>
